Patents Assigned to Board of Regents University of Nebraska-Lincoln
  • Publication number: 20110166827
    Abstract: Systems and methods for determining a trend in vertical track modulus are disclosed in accordance with embodiments of the present invention. Vertical deflection data is collected along a particular section of railroad track. A first set of vertical track modulus is determined, based in part, on the collected vertical deflection data. At a second time, vertical deflection data is again collected along the particular section of railroad track to be used in determining a second set of vertical track modulus. At least the first and second sets of vertical track modulus are analyzed to determine a mathematical algorithm that facilitates developing a trend in the vertical track modulus of the railroad track.
    Type: Application
    Filed: March 11, 2011
    Publication date: July 7, 2011
    Applicant: Board of Regents of the University of Nebraska at Lincoln
    Inventors: Shane Michael Farritor, Sheng Lu
  • Publication number: 20090305347
    Abstract: The present invention is directed to recombinant nucleic acid constructs comprising nucleic acid sequences encoding a Pichia pastoris PIR secretion signal peptide for secretion or an anchor domain peptide for surface display of a heterologous polypeptide. The present invention is further directed to methods for obtaining a heterologous polypeptide secreted into the culture medium or displayed on the cell surface. The present invention is also directed to transformed cells containing the recombinant nucleic acid constructs.
    Type: Application
    Filed: June 2, 2009
    Publication date: December 10, 2009
    Applicant: BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN
    Inventor: Mehmet Inan
  • Publication number: 20090269807
    Abstract: Recombinant nucleic acid constructs for the efficient expression of eukaryotic selenoproteins and related methods for production of recombinant selenoproteins are provided. The nucleic acid constructs comprise novel selenocysteine insertion sequence (SECIS) elements. Certain novel SECIS elements of the invention contain non-canonical quartet sequences. Other novel SECIS elements provided by the invention are chimeric SECIS elements comprising a canonical SECIS element that contains a non-canonical quartet sequence and chimeric SECIS elements comprising a non-canonical SECIS element that contains a canonical quartet sequence. The novel SECIS elements of the invention facilitate the insertion of selenocysteine residues into recombinant polypeptides.
    Type: Application
    Filed: April 22, 2009
    Publication date: October 29, 2009
    Applicant: Board of Regents of the University of Nebraska- Lincoln
    Inventors: Vadim Gladyshev, Sergey Novoselov
  • Patent number: 7371571
    Abstract: Recombinant mycobacterial strains which overproduce essential biosynthetic enzymes of pathogenic mycobateria are provided. These strains overproduce enzymes involved in the synthesis and incorporation of D-alanine into mycobacterial peptidoglycan, the backbone of the mycobacterial cell wall. These overproducing strains may be used as reference strains in in vitro screening methods to identify antimycobacterial agents.
    Type: Grant
    Filed: December 17, 2003
    Date of Patent: May 13, 2008
    Assignee: Board of Regents University of Nebraska - Lincoln
    Inventors: Raul G. Barletta, Zhengyu Feng
  • Patent number: 6929799
    Abstract: The present invention is directed to D-alanine racemase mutants of mycobacterial species. The D-alanine racemase gene (alrA) is involved in the systhesis of D-alanine, a basic component of peptidoglycan that forms the backbone of the bacterial cell wall. The present invention is also directed to methods of making live-attenuated vaccines against pathogenic mycobacteria using such alrA mutants and to the vaccines made according to such methods. The present invention is further directed to use of alrA mutants in methods for screening antimycobacterial agents that are synergistic with peptidoglycan inhibitors. Finally, the present invention is directed to methods to identify new pathways of D-alanine biosynthesis for use in developing new drugs targeting peptidoglycan biosynthesis in mycobacteria and to identify vaccines useful against pathogenic mycobacteria.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: August 16, 2005
    Assignee: Board of Regents University of Nebraska-Lincoln
    Inventors: Raul G. Barletta, Ofelia Barletta-Chacon
  • Publication number: 20040241830
    Abstract: Recombinant mycobacterial strains which overproduce essential biosynthetic enzymes of pathogenic mycobateria are provided. These strains overproduce enzymes involved in the synthesis and incorporation of D-alanine into mycobacterial peptidoglycan, the backbone of the mycobacterial cell wall. These overproducing strains may be used as reference strains in in vitro screening methods to identify antimycobacterial agents.
    Type: Application
    Filed: December 17, 2003
    Publication date: December 2, 2004
    Applicant: The Board of Regents, University of Nebraska-Lincoln
    Inventors: Raul G. Barletta, Zhengyu Feng
  • Publication number: 20040185056
    Abstract: Vaccines for pathogenic strains of bovine herpesvirus 1 (BHV-1) which are based on attenuated BHV-1 having a mutation in the latency-related gene are provided. Live, attenuated vaccines are also provided which express antigens from other viral or bacterial pathogens and thus form the basis of a variety of vaccines.
    Type: Application
    Filed: January 5, 2004
    Publication date: September 23, 2004
    Applicant: Board of Regents, University of Nebraska-Lincoln
    Inventor: Clinton J. Jones
  • Patent number: 6673537
    Abstract: The invention is directed to novel promoters or mutants thereof from Chlorella virus DNA methyltansferase genes. A Chlorella virus gene promoter is operably linked to a first and/or second DNA sequence encoding a gene that is different from the Chlorella virus to form an expression cassette. An expression cassette can be introduced into prokaryotic and/or eukaryotic cells and can provide for a high level of expression of the gene encoded by the first and/or second DNA sequence. The invention also provides a method for screening other Chlorella virus genes for promoters that can function to express a heterologous gene in prokaryotic and/or eukaryotic hosts.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: January 6, 2004
    Assignee: Board of Regents, University of Nebraska-Lincoln
    Inventors: Amitava Mitra, James L. Van Etten
  • Patent number: 6600177
    Abstract: The present invention relates to the fabrication of a boron carbide/boron semiconductor devices. The results suggest that with respect to the approximately 2 eV band gap pure boron material, 0.9 eV band gap boron carbide (B5C) acts as a p-type material. Both boron and boron carbide (B5C) thin films were fabricated from single source borane cage molecules using plasma enhanced chemical vapor deposition (PECVD). Epitaxial growth does not appear to be a requirement. We have doped boron carbide grown by plasma enhanced chemical vapor deposition. The source gas closo-1,2-dicarbadecaborane (orthocarborane) was used to grow the boron carbide while nickelocene (Ni(C5H5)2) was used to introduce nickel into the growing film. The doping of nickel transformed a B5C material p-type relative to lightly doped n-type silicon to an n-type material. Both p-n heterojunction diodes and n-p heterojunction diodes with n- and p-type Si [1,1,1] respectively.
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: July 29, 2003
    Assignee: Board of Regents, University of Nebraska-Lincoln
    Inventor: Peter A. Dowben
  • Patent number: 6489589
    Abstract: The present invention teaches various femtosecond machining and drilling apparatus and processes for fabricating tools and the like from both traditional and non-traditional materials. Also described are novel tools such as scalpels, and nozzles fabricated from the apparatus and processes of the present invention. Likewise, the present invention may be utilized in both a novel propulsion system and the production of materials formed from nanometer sized particles and the like.
    Type: Grant
    Filed: March 5, 1998
    Date of Patent: December 3, 2002
    Assignee: Board of Regents, University of Nebraska-Lincoln
    Inventor: Dennis R. Alexander
  • Patent number: 6440786
    Abstract: The present invention relates to the fabrication of a boron carbide/boron semiconductor devices. The results suggest that with respect to the approximately 2 eV band gap pure boron material, 0.9 eV band gap boron carbide (B5C) acts as a p-type material. Both boron and boron carbide (B5C) thin films were fabricated from single source borane cage molecules using plasma enhanced chemical vapor deposition (PECVD). Epitaxial growth does not appear to be a requirement. We have doped boron carbide grown by plasma enhanced chemical vapor deposition. The source gas close-1,2-dicarbadecaborane (orthocarborane) was used to grow the boron carbide while nickelocene (Ni(C5H5)2) was used to introduce nickel into the growing film. The doping of nickel transformed a B5C material p-type relative to lightly doped n-type silicon to an n-type material. Both p-n heterojunction diodes and n-p heterojunction diodes with n- and p-type Si [1,1,1] respectively.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: August 27, 2002
    Assignee: Board of Regents, University of Nebraska-Lincoln
    Inventor: Peter A. Dowben
  • Patent number: 6392032
    Abstract: Heavily fluorinated sugar analogs of formula wherein R1 is selected from alkyl, alkenyl, aryl, —CH2—O-alkyl, —CH2—O-aryl, —CH2OPO3H, —CH2—O-carbohydrate, —CH2—NH-peptide, or —CH2—O-peptide; wherein R2 is selected from hydroxy, —O-carbohydrate, —NH-peptide, wherein R3 is selected from H, halogen, lower alkyl, lower alkenyl, lower haloalkyl, lower haloalkenyl, amino, mono- or di-lower alkylamino; wherein R4 is selected from amino, hydroxy, alkoxy, or halogen; and wherein R5 is H or amino. The compounds of formula (I) are useful as antiviral and antineoplastic agents and the compounds of formula (II) are useful as plant growth inhibitors and herbicides.
    Type: Grant
    Filed: September 2, 1999
    Date of Patent: May 21, 2002
    Assignee: Board of Regents University of Nebraska-Lincoln
    Inventor: Stephen G. Dimagno
  • Patent number: 6379664
    Abstract: Thioltransferase and derivatives thereof are provided. Methods of treating or preventing cataract formation comprising administering thioltransferase or a derivative thereof are also provided. Thioltransferase or derivatives thereof are also useful for treating or preventing diseases resulting from or associated with oxidative stress. Human lens thioltransferase and a DNA sequence encoding the same are also provided.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: April 30, 2002
    Assignee: Board of Regents University of Nebraska-Lincoln
    Inventors: Marjorie F. Lou, Nalini Raghavachari, Fengyu Qiao
  • Publication number: 20020045300
    Abstract: The present invention relates to the fabrication of a boron carbide/boron semiconductor devices. The results suggest that with respect to the approximately 2 eV band gap pure boron material, 0.9 eV band gap boron carbide (B5C) acts as a p-type material. Both boron and boron carbide (B5C) thin films were fabricated from single source borane cage molecules using plasma enhanced chemical vapor deposition (PECVD). Epitaxial growth does not appear to be a requirement. We have doped boron carbide grown by plasma enhanced chemical vapor deposition. The source gas closo-1,2-dicarbadecaborane (orthocarborane) was used to grow the boron carbide while nickelocene (Ni(C5H5)2) was used to introduce nickel into the growing film. The doping of nickel transformed a B5C material p-type relative to lightly doped n-type silicon to an n-type material. Both p-n heterojunction diodes and n-p heterojunction diodes with n- and p-type Si [1,1,1] respectively.
    Type: Application
    Filed: November 16, 2001
    Publication date: April 18, 2002
    Applicant: Board of Regents, University of Nebraska Lincoln
    Inventor: Peter A. Dowben
  • Patent number: 6265333
    Abstract: A fiber reinforced composite material comprising a resin matrix and primary reinforcement fibers and further comprising secondary, smaller diameter, reinforcement fibers at one or more ply interfaces, or portion thereof, provides improved interlaminar toughness, strength, and delamination resistance without substantial reduction of in-plane properties and without substantial increase in weight. In one embodiment, the small fibers are attached to one side of a conventional prepreg prior to lamination. The small fibers are flexible and are expected to conform to the shape and distribution of the primary reinforcing fibers at the interface.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: July 24, 2001
    Assignee: Board of Regents, University of Nebraska-Lincoln
    Inventors: Yuris A. Dzenis, Darrell H. Reneker
  • Patent number: 6139907
    Abstract: A high coercivity longitudinal recording media comprising FePt or similar thin films that are vacuum deposited by RF and DC sputtering. The as-deposited multilayered films are subjected to vacuum annealing. Due to the formation of the ordered phases of FePt or the like, which have very high crystal anisotropy, the annealed FePt films have large coercivity and fine grain size, suitable for use as ultra-high density magnetic recording media.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: October 31, 2000
    Assignee: Board of Regents, University of Nebraska-Lincoln
    Inventors: David J. Sellmyer, Chun-Ping Luo
  • Patent number: 6099834
    Abstract: The invention is directed to compositions which alter the health of invertebrate organisms by affecting eicosanoid-mediated immune responses, and methods of using the compositions. The invention provides pharmaceutical compositions and biopesticide compositions. The pharmaceutical composition is composed of an effective amount of at least one biologically active agent which enhances or inhibits eicosanoid-mediated immune responses in invertebrate species and a physiological compatible carrier. The biopesticide composition is composed of a biopesticidal amount of an inhibitor of eicosanoid-mediated immune responses in invertebrates and a physiologically acceptable carrier. The pharmaceutical compositions are useful to treat invertebrate species to enhance or inhibit immune responses. The biopesticide composition is useful to control the growth of or eradicate invertebrate pests. Methods are provided for determining which and what amounts of the biologically active agents are useful in the composition.
    Type: Grant
    Filed: August 18, 1997
    Date of Patent: August 8, 2000
    Assignee: Board of Regents University of Nebraska-Lincoln
    Inventor: David W. Stanley
  • Patent number: 6036906
    Abstract: A precast, prestressed concrete joist having web openings through which mechanical and electrical equipment may pass. In an exemplary embodiment, the joist comprises generally horizontal opposite top and bottom concrete members with a concrete web interposed between them. This web may have openings through which mechanical and electrical equipment may pass. Prestress steel strands may extend lengthwise through both the top and bottom members to provide prestress in the concrete joist. The concrete joist may further comprise strand restraining devices for deflecting the prestress steel strands. The precast, prestressed concrete joist having a web opening may be constructed using a reusable casting apparatus. This casting apparatus comprises a prestressing bed onto which a frame may be mounted. The frame provides a means of applying tension to the prestress steel strands and of supporting prestress strand restraining devices.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: March 14, 2000
    Assignee: Board of Regents University of Nebraska, Lincoln
    Inventors: Maher K. Tadros, Amin Einea, Mohsen Saleh
  • Patent number: PP20013
    Abstract: A new and distinct Penstemon plant characterized by an upright, dense habit with very dark foliage, flowers of light purple shades, and excellent vigor.
    Type: Grant
    Filed: December 10, 2007
    Date of Patent: May 19, 2009
    Assignee: Board of Regents of the University of Nebraska-Lincoln
    Inventor: Dale Tennis Lindgren
  • Patent number: PP11373
    Abstract: A vegetatively reproduced buffalograss cultivar named `NE91-118` is distinguished from other commercially produced buffalograss varieties by its excellent turfgrass color, cold tolerance, high density, low growth habit, and rate of establishment. `NE91-118` is also distinguished by molecular markers and nuclear DNA content. `NE91-118` is suitable for use in low to medium maintenance situations in arid and semi-arid climates of United States and Canada.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: May 9, 2000
    Assignee: Board of Regents University of Nebraska-Lincoln
    Inventors: Terrance P. Riordan, Frederick P. Baxendale, Roch E. Gaussoin, Jennifer M. Johnson-Cicalese, Paul G. Johnson, Edward John Kinbacher